Not all enterprise scheduling solutions are created equal.
Before highlighting the features that every health system should include when implementing an enterprise scheduling solution, it makes sense to level set on the topic. Using the term “enterprise” to describe a scheduling solution means that the system must be designed to access all venues of care across the full spectrum of a patient’s healthcare journey. This means consumers will be presented with an integrated scheduling platform
Read More
Aevice Health Secures FDA Clearance for Smart Stethoscope Wearable for Respiratory Monitoring
What You Should Know:
- Aevice Health, a Singapore-based provider of remote respiratory monitoring solutions today announced that its AI-powered, smart stethoscope wearable, the AeviceMD, has received clearance from the U.S. Food and Drug Administration (FDA) as a Class II medical device under the 510(k) route.
- This clearance empowers the company to market and provide their novel remote monitoring platform to health systems across the country, expanding access to a
Read More
SiPhox Health Secures $27M for Lab-Grade Home Health Testing with Silicon Photonics
What You Should Know:
- Today, SiPhox Health, a Burlington, MA-based company building the next generation of lab-grade home health testing with silicon photonics raises $27M in funding, including a $10M Seed led by Khosla Ventures and Y Combinator, and a $17M Series A led by Intel Capital.
- The SiPhox Home and Health testing systems offer innovative and efficient blood collection solutions for consumers, healthcare systems, pharmaceutical companies, and research teams focusing on
Read More
Teladoc Health & Microsoft Expands Generative AI Integration
What You Should Know:
- Teladoc Health today announced an integration expansion with Microsoft, leveraging AI to help minimize administrative burden and identify potential hazards.
- The integrated solutions will enhance the power of our Solo platform for hospitals and health systems to better support the clinical workforce. These innovations powered by Microsoft AI tools will minimize administrative burden by automating clinical documentation during virtual and in-patient care.
-
Read More
Peterson Center on Healthcare Launches $50M Institute to Evaluate Digital Health
What You Should Know:
- The Peterson Center on Healthcare today launched the Peterson Health Technology Institute (PHTI), an independent non-profit that provides rigorous, evidence-based assessments of digital health technologies.
- Launched with a commitment of $50M, PHTI will analyze clinical benefits and economic impact, as well as the technologies’ effects on health equity, privacy, and security.
- PHTI will monitor the evolving pipeline of emerging digital health
Read More
UK Startup OrganOx Secures $32.6M for Liver Transplantation Device
What You Should Know:
- OrganOx, a United Kingdom-based medical technology company committed to making every donated organ count with metra®, a fully automated normothermic machine perfusion (NMP) device for liver transplantation raises £25M ($32.6M USD) in a growth round led by Lauxera Capital Partners (“Lauxera”) with support from existing investors.
- The proceeds from the funding will enable OrganOx to significantly expand its commercial footprint across strategically key areas
Read More
PE Firm Thoma Bravo Makes Strategic Investment in Bluesight & Medacist Acquisition
What You Should Know:
- Today Thoma Bravo, a private equity software investment firm, announced a strategic growth investment in Bluesight, the Medication Intelligence™ Company. Current investor New Leaf Ventures will remain invested in the business. Financial terms of the transaction were not disclosed.
- This investment will support Bluesight's acquisition of Medacist, the lead innovator in drug diversion monitoring, and drive the growth of Bluesight's inventory management and
Read More
Eli Lilly Acquires Obesity Drug Maker Versanis for $1.9B
What You Should Know:
Eli Lilly announced an agreement to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases for $1.925B in cash. Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab is currently being assessed in the BELIEVE Phase 2b study alone and in combination with
Read More
Causaly Secures $60M to Accelerate AI-Powered Biomedical Research
What You Should Know:
Causaly, the leading AI platform for biomedical research raises $60M in Series B funding led by ICONIQ Growth, with participation from Index Ventures, Marathon Venture Capital, EBRD, Pentech Ventures and Visionaries Club. Strategic individuals also participated in the round, including Alex Gorsky (former Chairman and CEO of Johnson & Johnson) and Olivier Pomel (CEO and Co-Founder of Datadog). The investment brings the total funding raised to $93 million,
Read More
Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices
What You Should Know:
The Israel Innovation Authority announced today a NIS 113M ($31M USD) investment for the establishment of a center that will provide research and development (R&D) infrastructure for bio-devices based on bio-chips. The investment is part of the National Bio-Convergence Program.Bio-convergence represents the integration of biology and life sciences with engineering and software technologies. The investment is directed at companies dedicated to developing key
Read More
